Search results for “Anti ctla 4” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 427 patents, we discovered top 63 key players by total patent application. Bristol Myers Squibb Co., MedImmune Ltd., Pfizer Products, Inc. are dominant in this area. They take 34.66% of the total patent filing.
Bristol Myers Squibb Co.
New York, United States
Patent: 77
MedImmune Ltd.
Cambridgeshire, United Kingdom
Patent: 38
Pfizer Products, Inc.
Connecticut, United States
Patent: 33
Ono Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 27
Pfizer Inc.
New York, United States
Patent: 25
Agenus, Inc.
Massachusetts, United States
Patent: 20
MedImmune LLC
Louisiana, United States
Patent: 20
ZymoGenetics, Inc.
Washington, United States
Patent: 18
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 16
CytomX Therapeutics, Inc.
California, United States
Patent: 13
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 8 patents, we discovered top 2 start-ups by total patent application.
STARTUP
Checkmate Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 6
STARTUP
Oncoc4 Inc
undefined undefined
Patent: 2
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 72 patents applied in the last 5 years. We discover 36 most active companies in this area. The fast-growing Bristol Myers Squibb Co., Regeneron Pharmaceuticals, Inc., Replimune Ltd. take 34.72% of patent filing during this period.
Bristol Myers Squibb Co.
New York, United States
Patent: 13
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 7
Replimune Ltd.
United Kingdom
Patent: 5
MedImmune LLC
Louisiana, United States
Patent: 4
Amgen, Inc.
California, United States
Patent: 4
OncoImmune, Inc.
United States
Patent: 4
Memorial Sloan Kettering Cancer Center
New York, United States
Patent: 3
CytomX Therapeutics, Inc.
California, United States
Patent: 3
MedImmune Ltd.
Cambridgeshire, United Kingdom
Patent: 3
WuXi Biologics Ireland Ltd.
Ireland
Patent: 3
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 72 patents in last 5 years, we discover 15 new entrants. Replimune Ltd., Amgen, Inc., WuXi Biologics Ireland Ltd. are the most active new entrants in this area.
Replimune Ltd.
United Kingdom
Patent: 5
Amgen, Inc.
California, United States
Patent: 4
WuXi Biologics Ireland Ltd.
Ireland
Patent: 3
Institut Gustave Roussy EURL
France
Patent: 2
University of Maryland Greenebaum Cancer Center
United States
Patent: 2
Cancer Prevention and Treatment Center of Sun Yat sen University (Affiliated Cancer Hospital of Sun Yat sen University, Cancer Research Institute of Sun Yat sen University)
undefined undefined
Patent: 2
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 2
Dongda Biotechnology (Suzhou) Co., Ltd.
Jiangsu Sheng, China
Patent: 1
New York University
New York, United States
Patent: 1
Protagen AG
Nordrhein-Westfalen, Germany
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 95 patents, we discovered top 13 universities and scientific research institutions by total patent application. The Johns Hopkins University, The University of Chicago, University of California are dominant in this area. They take 64.21% of the total patent filing.
The Johns Hopkins University
United States
Patent: 13
The University of Chicago
Illinois, United States
Patent: 5
University of California
California, United States
Patent: 4
University of Tokyo
Tokyo-to, Japan
Patent: 4
Guangxi Medical University
Guangxi Zhuangzu Zizhiqu, China
Patent: 4
University of Zurich
ZURICH, Switzerland
Patent: 4
Keio University
Tokyo-to, Japan
Patent: 3
Institut Gustave Roussy EURL
France
Patent: 2
New York University
New York, United States
Patent: 1
Dartmouth College
New Hampshire, United States
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: